News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
DeepHRD predicts HRD from routine biopsy slides
Photo from Erik Bergstrom/LinkedIn
Aug 6, 2024, 14:09

DeepHRD predicts HRD from routine biopsy slides

Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared a post on X, about recent paper published in Journal of Clinical Oncology:

Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides.

Authors: Erik N. Bergstrom, Ammal Abbasi, Marcos Díaz-Gay, Loïck Galland, Sylvain Ladoire, Scott M. Lippman, Ludmil B. Alexandrov.

Elvina Almuradova

”DeepHRD, a new AI tool, predicts homologous recombination deficiency from routine biopsy slides. In studies, it outperformed traditional tests, predicting better outcomes for breast and ovarian cancer patients.”

Source: Elvina Almuradova/X

Ammal Abbasi Breast Cancer cancer Elvina Almuradova Erik N. Bergstrom European School of Oncology homologous recombination deficiency Journal of Clinical Oncology Loïck Galland Ludmil B. Alexandrov Marcos Díaz-Gay OncoDaily Oncology Ovarian Cancer Scott M. Lippman Sylvain Ladoire
Special Coverage
Science
Dec 21, 2024, 13:18
Ruzanna Papyan: The Impact of Telemedicine on Improving Soft Tissue and Bone Tumor Management in Armenia
Science
Dec 21, 2024, 13:12
Myeloma Paper of the Day, December 21st, suggested by Robert Orlowski
Blog
Dec 21, 2024, 13:06
Varsha Gupta: Fertility preservation causes no significant delay in cancer treatment initiation and outcomes
Cancer Types
Dec 21, 2024, 13:05
Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment
Insight
Dec 21, 2024, 12:45
Practical treatment strategies and novel therapies for HR positive/HER2 negative advanced breast cancer
Insight
Dec 21, 2024, 12:39
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer
Blog
Dec 21, 2024, 12:18
NCI Symposium on Translational Technology for Global Health
Blog
Dec 21, 2024, 12:14
Paolo Tarantino: Ending of a terrific 3-year cycle of PhD at The University of Milan
Blog
Dec 21, 2024, 11:52
Gevorg Tamamyan's first message as New POEM President
Blog
Dec 21, 2024, 11:30
Kyaw Thein: Tissue-Agnostic Drug Development in Cancer
Dialogues
Dec 21, 2024, 11:29
Beyond the Cancer Diagnosis: Dialogue with Marianne Arab, Hosted by Adrian Pogacian
Blog
Dec 21, 2024, 11:27
Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona